 Daily Mail |
Positive Results in Trial for New Asthma Treatment
news Stories Synairgen, a drug development company that spun out of the University of Southampton, United Kingdom, has announced positive results of a phase 2 clinical trial of its asthma drug SNG001. The trial investigated the potential for SNG001 to protect … Positive SNG001 Phase II Asthma Clinical Trial Data Asthma drug 'protects sufferers from life-threatening symptoms caused by … Synairgen's 'breakthrough' asthma drug shines in Phase II trial |
View full post on asthma – Google News